Nexalis Therapeutics Limited (ASX:NX1)
0.0230
-0.0020 (-8.00%)
At close: Apr 29, 2026
-8.00% (1Y)
| Market Cap | 5.82M |
| Revenue (ttm) | 986.43K |
| Net Income (ttm) | -1.62M |
| Shares Out | 253.04M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 206,260 |
| Average Volume | 116,521 |
| Open | 0.0230 |
| Previous Close | 0.0250 |
| Day's Range | 0.0230 - 0.0230 |
| 52-Week Range | 0.0170 - 0.0480 |
| Beta | 0.06 |
| RSI | 51.05 |
| Earnings Date | May 22, 2026 |